AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced.  New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a hub of world-leading science and technology companies.  Tres […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!